TITLE

IOM report makes major drug safety recommendation

PUB. DATE
December 2012
SOURCE
Medical Ethics Advisor;Dec2012, Vol. 28 Issue 12, p141
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article offers information on the report from the Institute of Medicine (IOM) in the U.S. which revealed that the U.S. Food and Drug Administration's (FDA) post marketing approval of the drug fails to ensure drug safety. It mentions that a full lifecycle approach to drug regulation is being promoted by IOM. It further informs that the ethicality of the researches involving human subjects can proved by reporting it publicly.
ACCESSION #
83760428

 

Related Articles

  • Report finds FDA oversight lacking on pediatric devices.  // Materials Management in Health Care;Sep2005, Vol. 14 Issue 9, p12 

    Reports on the findings of the study conducted by the Institute of Medicine (IOM), a nonprofit institution, which addresses the efficiency of the U.S. Food and Drug Administration (FDA). Comments of IOM on the administration's lack of effective procedures to monitor post-market safety studies of...

  • The US FDA requires a "new vision of drug safety.".  // Reactions Weekly;11/4/2006, Issue 1126, p3 

    The article reports on the recommendation of the Institute of Medicine Committee on the Assessment of the U.S. Drug Safety System for U.S. Food and Drug Administration to acquire a culture of safety in which the risks and benefits of medications are examined during their entire market life. The...

  • Institute of Medicine Report Slams FDA.  // Quality Progress;Nov2006, Vol. 39 Issue 11, p16 

    The article reports on an independent federal report from the United States Institute of Medicine. The report echoes the harshest critics of the U.S. Food and Drug Administration's drug safety regimen. According to the report, the drug safety system of the country is feeble in its drug approval...

  • Institute of Medicine, Congress Seek Solutions to FDA's Safety Woes Through Reform, Funding. Finkelstein, Joel B. // JNCI: Journal of the National Cancer Institute;1/17/2007, Vol. 99 Issue 2, p104 

    The article reports on the findings of the Institute of Medicine's Committee on the Assessment of the U.S. Drug Safety System, regarding the lack of certainty over safety of new drugs as approved by the Food and Drug Administration (FDA). According to sources, it is not a question of ability,...

  • Will the FDA Regulate the Amount of Salt in Food?  // New American (08856540);5/24/2010, Vol. 26 Issue 11, p7 

    The article reports on the statement of the U.S. Food and Drug Administration (FDA) regarding its support for reduction of salts in daily foods by Americans. According to FDA's news release, the agency is yet to draft regulations or policies to regulate sodium content in foods. It adds that FDA...

  • IOM: FDA Needs Revamped Regulatory Framework.  // Chain Drug Review;6/7/2010, Vol. 32 Issue 10, p236 

    The article reports on the suggestions made by the Institute of Medicine to Food & Drug Administration (FDA) suggesting the revamp of its regulatory framework in the evaluation of food benefits and nutritional supplements in Washington.

  • Accelerating Drug Development. Wechsler, Jill // Pharmaceutical Technology;Mar2007, Vol. 31 Issue 3, p32 

    The article focuses on a report plans by the U.S. Food and Drug Administration that addresses many of the drug-safety issues in response to a set of recommendations from the Institute of Medicine. The report "The Future of Drug Safety: Promoting and Protecting the Health of the Public" outlines...

  • Experts Urge Major Overhaul at FDA. Wechsler, Jill // Applied Clinical Trials;Nov2006, Vol. 15 Issue 11, p22 

    The article reports on the proposal for better prescription drug testing regulations by the Institute of Medicine (IOM) to the Food and Drug Administration (FDA) in the U.S. Due to the high-profile drug withdrawals and safety alerts, the public has raised doubts on the ability of FDA and the...

  • SAFETY CONCERNS. Nall, Stephanie // Journal of Commerce (1542-3867);4/16/2012, Vol. 13 Issue 14, p26A 

    The article focuses on concerns of safety of imported food. It makes reference to the 300-page report of the Institute of Medicine (IOM) on April 2, 2012 concerning imported food and the role of the U.S. Food and Drug Administration (FDA). It discusses the alleged failure of the FDA in...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics